Press Releases Viromed Medical AG

Equities

End-of-day quote BOERSE DUESSELDORF Other stock markets 18:00:00 2024-05-28 EDT			5-day change	1st Jan Change
2.2 ^EUR	-4.35%		-10.57%	-45.00%

2022

DD: Viromed Medical AG: Perbamed Invest GmbH, buy	04-26	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	04-26	EQ
Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential	04-22	EQ
Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected	04-22	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	04-08	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-20	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-20	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-12	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-12	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-12	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-06	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-06	EQ
DD: Viromed Medical AG: Perbamed Invest GmbH, buy	02-06	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ
DD: Viromed Medical AG: Uwe Perbandt, buy	02-02	EQ

No results for this search